Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary…
CHANGZHOU, China, Oct. 2, 2025 /PRNewswire/ -- TrinaTracker, a provider of smart solar tracking solutions under Trinasolar, announced that it…
Geninfinity introduces a secure system that lets users create digital identities and manage their educational records independently. This new feature…